Exact Mass: 609.343

Exact Mass Matches: 609.343

Found 37 metabolites which its exact mass value is equals to given mass value 609.343, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

tiamulin fumarate

Thiamutilin fumarate

C32H51NO8S (609.3335)

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic

apicidin B

C33H47N5O6 (609.3526)

apicidin C

C33H47N5O6 (609.3526)

D004791 - Enzyme Inhibitors > D056572 - Histone Deacetylase Inhibitors

IHVLE

Ile His Val Leu Glu

C28H47N7O8 (609.3486)

b-D-Glucopyranosiduronic acid, (3a,5b)-24-[(carboxymethyl)amino]-24-oxocholan-3-yl

C32H51NO10 (609.3513)

L-Valinamide, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-2-methylalanyl-N-[(1S,2S)-1-[(1R)-2-carboxy-1-methoxyethyl]-2-methylbutyl]-N-methyl-

C34H47N3O7 (609.3414)

Lnape 5:0/N-22:6

C32H52NO8P (609.343)

Lnape 22:6/N-5:0

C32H52NO8P (609.343)

Lnape 24:6/N-3:0

C32H52NO8P (609.343)

Lnape 3:0/N-24:6

C32H52NO8P (609.343)

[3-acetyloxy-2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C32H52NO8P (609.343)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate

C32H52NO8P (609.343)

N-[(E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxydec-4-en-2-yl]hexanamide

C28H51NO13 (609.336)

N-[(E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxydodec-4-en-2-yl]butanamide

C28H51NO13 (609.336)

N-[(E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyoct-4-en-2-yl]octanamide

C28H51NO13 (609.336)

N-[(E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxynon-4-en-2-yl]heptanamide

C28H51NO13 (609.336)

N-[(E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytridec-4-en-2-yl]propanamide

C28H51NO13 (609.336)

N-[(E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytetradec-4-en-2-yl]acetamide

C28H51NO13 (609.336)

N-[(E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyundec-4-en-2-yl]pentanamide

C28H51NO13 (609.336)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-undec-4-enoyl]oxypropan-2-yl] (5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoate

C32H52NO8P (609.343)

DGCC 22:5;O2

C32H51NO10 (609.3513)

PC 20:5/4:1

C32H52NO8P (609.343)

PC 22:6/2:0

C32H52NO8P (609.343)

PC 24:6

C32H52NO8P (609.343)

LNAPE 27:6

C32H52NO8P (609.343)

ST 24:2;O5;HexNAc

C32H51NO10 (609.3513)

PAF(22:6)

C32H52NO8P (609.343)

(3s,6s,9s,15ar)-1,4,7-trihydroxy-9-isopropyl-6-[(1-methoxyindol-3-yl)methyl]-3-(6-oxooctyl)-3h,6h,9h,12h,13h,14h,15h,15ah-pyrido[1,2-a]1,4,7,10-tetraazacyclododecan-10-one

C33H47N5O6 (609.3526)

(3s,6s,9s,14ar)-1,4,7-trihydroxy-6-[(1-methoxyindol-3-yl)methyl]-3-(6-oxooctyl)-9-(sec-butyl)-3h,6h,9h,12h,13h,14h,14ah-pyrrolo[1,2-a]1,4,7,10-tetraazacyclododecan-10-one

C33H47N5O6 (609.3526)

(2r)-3-[(3s,6s,9s,16s,21as)-1,10-dihydroxy-3,6-diisopropyl-5,8,9-trimethyl-4,7,14,17-tetraoxo-3h,6h,9h,12h,13h,16h,19h,20h,21h,21ah-pyrrolo[1,2-d]1-oxa-4,7,10,13,16-pentaazacyclononadecan-16-yl]-2-methylpropanoic acid

(2r)-3-[(3s,6s,9s,16s,21as)-1,10-dihydroxy-3,6-diisopropyl-5,8,9-trimethyl-4,7,14,17-tetraoxo-3h,6h,9h,12h,13h,16h,19h,20h,21h,21ah-pyrrolo[1,2-d]1-oxa-4,7,10,13,16-pentaazacyclononadecan-16-yl]-2-methylpropanoic acid

C29H47N5O9 (609.3374)

3-{1,10-dihydroxy-3,6-diisopropyl-5,8,9-trimethyl-4,7,14,17-tetraoxo-3h,6h,9h,12h,13h,16h,19h,20h,21h,21ah-pyrrolo[1,2-d]1-oxa-4,7,10,13,16-pentaazacyclononadecan-16-yl}-2-methylpropanoic acid

C29H47N5O9 (609.3374)